Market Overview
The Prostate Specific Antigen (PSA) Testing
market is predicted to develop at a compound annual growth rate (CAGR) of 12.10%
from 2024 to 2033, when it is projected to reach USD 9.12 billion, based on an
average growth pattern. The market is estimated to reach a value of USD 3.46
billion in 2024.
SOURCE: We Market Research
A blood test
called prostate-specific antigen (PSA) testing is used to screen for prostate
cancer and track its advancement. A protein called PSA, which aids in
liquefying semen, is produced by the prostate gland. Increased PSA values can
be a sign of several prostate problems, including cancer. PSA testing has
limits even if it's a useful tool for early cancer detection. This is because
elevated levels can also be caused by diseases other than cancer. It is possible
for there to be false positives or negatives, which could result in
overtreatment or missed diagnosis. In order to provide accurate assessment and
well-informed decision-making regarding prostate health, its interpretation
necessitates careful thought and frequently involves additional diagnostic
techniques, such as biopsies.
There are
various important factors are driving the market for prostate-specific antigen
(PSA) testing are, there is a growing need for PSA testing due to rising
awareness and proactive healthcare programs for early cancer diagnosis.
Furthermore, an increase in the prevalence of prostate-related problems brought
on by an aging global population, especially in industrialized nations, is
driving the market. Adoption is accelerated by technological developments in
diagnostic methods and the creation of more precise and sensitive PSA tests,
which improve accuracy. Additionally, an increase in research and development
efforts together with the global incidence of prostate cancer serve to further
drive market expansion. Together, these elements foster innovation, market
growth, and increased accessibility to PSA testing, which helps to shape the
market's future.
Market Scope
Report Attributes |
Description |
Market Size in 2024 |
USD 3.46 Billion |
Market Forecast in 2033 |
USD 9.12 Billion |
CAGR % 2024-2033 |
12.10% |
Base Year |
2023 |
Historic Data |
2016-2022 |
Forecast Period |
2024-2033 |
Report USP
|
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
Segments Covered |
By Test Procedure, by Test Type, by Assays type, by Application and
By Region |
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Prostate Specific Antigen (PSA) Testing Industry:
Dynamics & Restrains
Market Drivers
Rising
Prevalence of Prostate Cancer - The growing
incidence of prostate cancer is a major driver behind the growth of the
prostate specific antigen (PSA) testing market. PSA testing is becoming more
popular as a result of the growing urge for early detection and surveillance
brought on by the rising incidence of prostate cancer worldwide. PSA testing is
a crucial diagnostic method that provides early treatment options and is
capable of detecting prostate cancer. The market for PSA testing has grown
significantly as a result of the pressing demand for efficient screening
techniques due to the rising incidence of prostate cancer. This development is
also significantly influenced by the knowledge of and emphasis on early
diagnosis.
Rising Patient
Preference for Early Diagnosis - Patients'
increasing need for early diagnosis is driving significant increase in the
market for prostate specific antigen (PSA) testing. People are actively
searching for preventive healthcare measures as they become more conscious of
the significance of early detection in enhancing treatment outcomes. In line
with patients' preferences for prompt therapies, PSA testing appears as a
critical tool in enabling early identification of prostate cancer. Healthcare
providers are increasingly incorporating PSA testing into routine screenings to
meet the growing demand from patients for early detection and improved
prognosis among individuals at risk of prostate cancer. This drive for quick
and accurate diagnostic methods is driving the market expansion.
Market restrains
Controversies
Surrounding Overdiagnosis and Overtreatment - Prostate
specific antigen (PSA) testing industry expansion is being hindered by
disagreements around overdiagnosis and overtreatment. Those who disagree assert
that treatments that are dangerous and ineffective could be the result of
elevated PSA levels. Fears about unnecessary medical treatments and false
positives have made both patients and healthcare practitioners cautious. As a
result, there is resistance in the market from those who question PSA testing's
overall efficacy. Weighing the benefits and drawbacks of testing becomes
essential because it influences decision-making and keeps PSA testing from
being universally recognized as a reliable tool. This highlights the ongoing
challenge of finding a cautious balance between early identification and potential
overtreatment.
We Market
Research: Prostate Specific Antigen
(PSA) Testing Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Prostate Specific Antigen (PSA) Testing Segmentation
Market- By Test Procedure Analysis
By Test Procedure, the Prostate Specific Antigen (PSA) Testing Market is Categories into Preliminary Tests, Confirmatory Tests. The Preliminary Tests segment accounts for the largest share of around 62% in 2024.
The ability to quickly screen people for
possible prostate problems is propels the preliminary tests subsegment of the
prostate specific antigen (PSA) testing market. These tests function as early
indicators, allowing for immediate diagnosis and further diagnoses in the
future.
The
following segments are part of an in-depth analysis of the global Prostate
Specific Antigen (PSA) Testing market:
Market Segments |
|
By Test Type |
·
Total Prostate Specific
Antigen Test (tPSA) ·
Complex Prostate Specific
Antigen Test (cPSA) ·
Free Prostate Specific
Antigen Test (fPSA) ·
Prostate Specific Antigen
Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR) ·
PCA3Test ·
Trans-rectal Ultrasound ·
Biopsy |
By Assays type |
·
Radioimmunoassay (RIA) ·
Enzyme Immunoassay (EIA) |
By Application |
·
Screening ·
Post-treatment Monitoring |
Prostate Specific Antigen (PSA) Testing Industry: Regional
Analysis
North America Market Forecast
North America dominate the Prostate Specific Antigen (PSA) Testing Market with the highest revenue generating market with share of more than 46%. Due to a strong healthcare system and increased cancer awareness, North America has a thriving PSA testing market. Although current discussions about overdiagnosis, government programs support early detection. Proactive screening for prostate cancer fuels market development, but cost concerns provide challenges.
Europe Market Statistics
Europe is the
second-largest market for Prostate Specific Antigen (PSA) Testing. Due to an
older population and well-established healthcare infrastructures, Europe is
showing signs of a developing PSA testing market. To guarantee successful
screening procedures, a balanced strategy is needed to handle the problems
posed by strict laws addressing false positives and ethical issues.
Asia Pacific Market Forecasts
Asia Pacific is expected
to be the fastest-growing market for Prostate Specific Antigen (PSA) Testing
during the forecast period. The Asia-Pacific area has seen an increase in the
demand for PSA testing as a result of increased rates of prostate cancer and
bettering healthcare facilities. Screening rates are affected by cultural and
awareness gaps, though, and for the market to continue growing, focused
education campaigns and standardized testing procedures are required.
Key Market Players
The Prostate
Specific Antigen (PSA) Testing Market is dominated by a few large companies,
such as
·
Abbott Laboratories
·
Beckman Coulter
·
Bio-Rad Laboratories, Inc.
·
F. Hoffmann-La Roche Ltd.
·
Ortho Clinical Diagnostics
·
Siemens Healthineers AG
·
Danaher Corporation
·
Mindray Medical International
Limited
·
Alere Inc.
·
Quidel Corporation
·
Others
1.
Global
Prostate Specific Antigen (PSA) Testing Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Prostate Specific Antigen
(PSA) Testing Market Scope and Market Estimation
1.2.1. Global Prostate Specific Antigen
(PSA) Testing Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market
forecast (2023 - 2033)
1.2.2. Global Prostate Specific Antigen
(PSA) Testing Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2033
1.3. Market Segmentation
1.3.1. Component of Global Prostate
Specific Antigen (PSA) Testing Market
1.3.2. Technology of Global Prostate
Specific Antigen (PSA) Testing Market
1.3.3. Assays type of Global Prostate
Specific Antigen (PSA) Testing Market
1.3.4. Region of Global Prostate
Specific Antigen (PSA) Testing Market
2.
Executive Summary
2.1. Global Prostate Specific Antigen (PSA) Testing Market Industry Trends
under COVID-19 Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Prostate Specific Antigen
(PSA) Testing Market Industry Development
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and
Restraints
2.3. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5. Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6. Value Chain / Ecosystem Analysis
2.7. Russia-Ukraine War Impacts
Analysis
2.8. Economic Downturn Analysis
2.9. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.
Global Prostate Specific Antigen
(PSA) Testing Market Estimates &
Historical Trend Analysis (2019 - 2022)
4.
Global Prostate Specific Antigen
(PSA) Testing Market Estimates &
Forecast Trend Analysis, by TEST PROCEDURE
4.1. Global Prostate Specific Antigen
(PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by TEST
PROCEDURE, 2019 to 2033
4.1.1. Preliminary Tests
4.1.2. Confirmatory Tests
5.
Global Prostate Specific Antigen
(PSA) Testing Market Estimates &
Forecast Trend Analysis, by Test Type
5.1. Global Prostate Specific Antigen
(PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Test Type,
2019 to 2033
5.1.1. Total Prostate Specific Antigen
Test (tPSA)
5.1.2. Complex Prostate Specific
Antigen Test (cPSA)
5.1.3. Free Prostate Specific Antigen
Test (fPSA)
5.1.4. Prostate Specific Antigen
Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR)
5.1.5. PCA3Test
5.1.6. Trans-rectal Ultrasound
5.1.7. Biopsy
6.
Global Prostate Specific Antigen
(PSA) Testing Market Estimates &
Forecast Trend Analysis, by Assays
type
6.1. Global Prostate Specific Antigen
(PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Assays type, 2019 to 2033
6.1.1. Radioimmunoassay (RIA)
6.1.2. Enzyme Immunoassay (EIA)
7.
Global Prostate Specific Antigen
(PSA) Testing Market Estimates &
Forecast Trend Analysis, by APPLICATION
7.1. Global Prostate Specific Antigen
(PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Assays type, 2019 to 2033
7.1.1. Screening
7.1.2. Post-treatment Monitoring
8.
Global Prostate Specific Antigen
(PSA) Testing Market Estimates &
Forecast Trend Analysis, by Region
8.1. Global Prostate Specific Antigen
(PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019
to 2033
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9.
North
America Prostate Specific Antigen (PSA) Testing
Market: Estimates & Forecast Trend
Analysis
9.1.
North
America Prostate Specific Antigen (PSA) Testing Market Assessments & Key
Findings
9.1.1. North America Prostate Specific
Antigen (PSA) Testing Market Introduction
9.1.2. North America Prostate Specific
Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
9.1.2.1. By TEST PROCEDURE
9.1.2.2. By Test Type
9.1.2.3. By Assays type
9.1.2.4. By APPLICATION
9.1.2.5. By Country
9.1.2.5.1. The U.S.
9.1.2.5.2. Canada
9.1.2.5.3. Mexico
10. Europe Prostate
Specific Antigen (PSA) Testing Market:
Estimates & Forecast Trend Analysis
10.1. Europe Prostate Specific Antigen
(PSA) Testing Market Assessments & Key Findings
10.1.1. Europe Prostate Specific Antigen
(PSA) Testing Market Introduction
10.1.2. Europe Prostate Specific Antigen
(PSA) Testing Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
10.1.2.1. By TEST PROCEDURE
10.1.2.2. By Test Type
10.1.2.3. By Assays type
10.1.2.4. By APPLICATION
10.1.2.5. By Country
10.1.2.5.1. Germany
10.1.2.5.2. U.K.
10.1.2.5.3. France
10.1.2.5.4. Italy
10.1.2.5.5. Spain
10.1.2.5.6. Russia
10.1.2.5.7. Rest of Europe
11. Asia Pacific Prostate
Specific Antigen (PSA) Testing Market:
Estimates & Forecast Trend Analysis
11.1. Asia Pacific Market Assessments
& Key Findings
11.1.1. Asia Pacific Prostate Specific
Antigen (PSA) Testing Market Introduction
11.1.2. Asia Pacific Prostate Specific
Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
11.1.2.1. By TEST PROCEDURE
11.1.2.2. By Test Type
11.1.2.3. By Assays type
11.1.2.4. By APPLICATION
11.1.2.5. By Country
11.1.2.5.1. China
11.1.2.5.2. Japan
11.1.2.5.3. India
11.1.2.5.4. Australia
11.1.2.5.5. South Korea
11.1.2.5.6. ASEAN
11.1.2.5.7. Rest of Asia Pacific
12. Middle East & Africa Prostate
Specific Antigen (PSA) Testing Market:
Estimates & Forecast Trend Analysis
12.1. Middle East & Africa Market
Assessments & Key Findings
12.1.1. Middle
East & Africa Prostate
Specific Antigen (PSA) Testing Market Introduction
12.1.2. Middle
East & Africa Prostate
Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million)
(2019 – 2033)
12.1.2.1. By TEST PROCEDURE
12.1.2.2. By Test Type
12.1.2.3. By Assays type
12.1.2.4. By APPLICATION
12.1.2.5. By Country
12.1.2.5.1. U.A.E.
12.1.2.5.2. Saudi Arabia
12.1.2.5.3. Egypt
12.1.2.5.4. South Africa
12.1.2.5.5. Rest of Middle East & Africa
13. South America
Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis
13.1. South America Market Assessments
& Key Findings
13.1.1. South America Prostate Specific
Antigen (PSA) Testing Market Introduction
13.1.2. South America Prostate Specific
Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
13.1.2.1. By TEST PROCEDURE
13.1.2.2. By Test Type
13.1.2.3. By Assays type
13.1.2.4. By APPLICATION
13.1.2.5. By Country
13.1.2.5.1. Brazil
13.1.2.5.2. Argentina
13.1.2.5.3. Colombia
13.1.2.5.4. Rest of South America
14. Competition Landscape
14.1. Global Prostate Specific Antigen
(PSA) Testing Market Competition Matrix & Benchmarking, by Leading Players
/ Innovators / Emerging Players / New Entrants
14.2. Global Prostate Specific Antigen
(PSA) Testing Market Competition White Space Analysis, By Assays type
14.3. Global Prostate Specific Antigen
(PSA) Testing Market Competition Heat Map Analysis, By Assays type
14.4. Global Prostate Specific Antigen
(PSA) Testing Market Concentration & Company Market Shares (%) Analysis,
2022
15. Company Profiles
15.1.
Abbott Laboratories
15.1.1. Company Overview & Key Stats
15.1.2. Financial Performance & KPIs
15.1.3. Product Portfolio
15.1.4. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
15.2. Beckman Coulter
15.3. Bio-Rad
Laboratories, Inc.
15.4. F. Hoffmann-La
Roche Ltd.
15.5. Ortho Clinical
Diagnostics
15.6. Siemens
Healthineers AG
15.7. Danaher
Corporation
15.8. Mindray
Medical International Limited
15.9. Alere Inc.
15.10. Quidel
Corporation
15.11. Creative
Diagnostics
15.12. Others
16. Research
Methodology
16.1. External Transportations /
Databases
16.2. Internal Proprietary Database
16.3. Primary Research
16.4. Secondary Research
16.5. Assumptions
16.6. Limitations
16.7. Report FAQs
17. Research Findings & Conclusion
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process